Trial Summary
The trial requires that your medication dosage for neuropsychiatric symptoms be stable for at least 2 weeks, so you may not need to stop taking your current medications if they meet this condition.
Research shows that cognitive rehabilitation, which includes retraining skills and teaching strategies, is effective for improving cognitive functions like memory and attention. This suggests that treatments like HEARS-SLP, which may involve similar rehabilitation techniques, could be beneficial for cognitive impairment.
12345The research articles reviewed do not provide specific safety data for the HEARS-SLP device or program. However, they discuss auditory training programs in general, which are typically considered safe for use in humans, focusing on improving hearing and speech perception.
678910The HEARS-SLP treatment is unique because it combines a device and a program specifically designed to address both hearing and cognitive challenges, unlike traditional hearing aids that mainly focus on sound amplification. This approach aims to improve listening strategies and cognitive skills, which are often not addressed by standard hearing aids.
1112131415Eligibility Criteria
This trial is for English-speaking individuals aged 60-100 with probable Alzheimer's or related dementia, who live at home and have stable medication dosing. They must have adult-onset hearing loss and a caregiver available to assist with the study.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Immediate Treatment
Participants receive immediate hearing rehabilitative intervention delivered by a speech-language pathologist
Delayed Treatment
Participants receive delayed hearing rehabilitative intervention delivered by a speech-language pathologist after a 1-month delay
Follow-up
Participants are monitored for changes in neuropsychiatric symptoms and quality of life post-intervention